Literature DB >> 19814579

Synchronous bilateral percutaneous nephrostolithotomy.

Steve K Williams1, David M Hoenig.   

Abstract

Various options are available for the treatment of patients with large, bilateral renal stones, including a staged percutaneous nephrostolithotomy (PCNL), synchronous PCNL with contralateral ureterorenoscopy, and synchronous bilateral PCNL. For patients with large bilateral renal stones, a synchronous bilateral PCNL may be offered if particular criteria are met. Overall outcomes reported for synchronous bilateral PCNL include high stone-free rates (95%-97%), low complication rates (9%-12%), short length of hospital stay (4-6 days), and low blood transfusion rates. Detailed cost analysis has revealed a significant cost advantage for synchronous vs staged bilateral PCNL; however, reimbursement practices reveal a significant financial disincentive for the surgeon to perform simultaneous bilateral PCNL. Here, we review the experience and current recommendations with synchronous bilateral PCNL for the treatment of patients with large, bilateral renal calculi.

Entities:  

Mesh:

Year:  2009        PMID: 19814579     DOI: 10.1089/end.2009.1538

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

1.  Bilateral same-session ureterorenoscopy: A feasible approach to treat pan-urinary stone disease.

Authors:  Bora Özveren; Murat Tugrul Eren; Hakan Özveri; Uğur Altuğ; Ahmet Şahin
Journal:  Arab J Urol       Date:  2017-10-09

2.  Simultaneous and synchronous bilateral endoscopic treatment of urolithiasis: a multicentric study.

Authors:  Oriol Angerri; Olga Mayordomo; Andres Koey Kanashiro; Felix Millan-Rodriguez; Francisco Maria Sanchez-Martin; Sung-Yo Cho; Eran Schreter; Mario Sofer; Saeed Bin-Hamri; Ahmed Alasker; Yiloren Tanidir; Tarik Emre Sener; Panagiotis Kalidonis; Joan Palou-Redorta; Esteban Emiliani
Journal:  Cent European J Urol       Date:  2019-05-30

3.  Bilateral single-session retrograde intra-renal surgery: A safe option for renal stones up to 1.5 cm.

Authors:  Punit Bansal; Neeru Bansal; Anand Sehgal; Subhash Singla
Journal:  Urol Ann       Date:  2016 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.